Publications

2001

Sahoo S, Hoda SA, Rosai J, DeLellis RA. Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution. Am J Clin Pathol. 2001;116(5):696-702.
Kulke MH, Thakore KS, Thomas G, Wang H, Loda M, Eng C, et al. Microsatellite instability and hMLH1/hMSH2 expression in Barrett esophagus-associated adenocarcinoma. Cancer. 2001;91(8):1451-7.
Johnson RA, Ince TA, Scotto KW. Transcriptional repression by p53 through direct binding to a novel DNA element. J Biol Chem. 2001;276(29):27716-20.
Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A. 2001;98(24):13790-5.
Kulke MH, Odze RD, Thakore KS, Thomas G, Wang H, Loda M, et al. Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma. Br J Cancer. 2001;84(6):748-53.
Siddiqui MT, Greene KL, Clark DP, Xydas S, Udelsman R, Smallridge RC, et al. Human telomerase reverse transcriptase expression in Diff-Quik-stained FNA samples from thyroid nodules. Diagn Mol Pathol. 2001;10(2):123-9.
Moscat J, Sanz L, Sanchez P, Diaz-Meco MT. Regulation and role of the atypical PKC isoforms in cell survival during tumor transformation. Adv Enzyme Regul. 2001;41:99-120.
Ellis FH, Xu X, Kulke MH, LoCicero J, Loda M. Malignant transformation of the esophageal mucosa is enhanced in p27 knockout mice. J Thorac Cardiovasc Surg. 2001;122(4):809-14.
Leitges M, Sanz L, Martin P, Duran A, Braun U, García JF, et al. Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. Mol Cell. 2001;8(4):771-80.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700